Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Other Stockholders Equity : ¥3,542 Mil (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Other Stockholders Equity?

Zhongyuan Union Cell & Gene Engineering's Other Stockholders Equity for the quarter that ended in Mar. 2025 was ¥3,542 Mil.

Zhongyuan Union Cell & Gene Engineering's quarterly Other Stockholders Equity declined from Sep. 2024 (¥3,532 Mil) to Dec. 2024 (¥172 Mil) but then increased from Dec. 2024 (¥172 Mil) to Mar. 2025 (¥3,542 Mil).

Zhongyuan Union Cell & Gene Engineering's annual Other Stockholders Equity increased from Dec. 2022 (¥133 Mil) to Dec. 2023 (¥158 Mil) and increased from Dec. 2023 (¥158 Mil) to Dec. 2024 (¥172 Mil).

Zhongyuan Union Cell & Gene Engineering Other Stockholders Equity Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Other Stockholders Equity Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Stockholders Equity

Get a 7-Day Free Trial

268.38

153.94

133.30

158.16

172.39

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Stockholders Equity	Get a 7-Day Free Trial															3,526.77	163.88	3,532.44	172.39	3,542.36

Zhongyuan Union Cell & Gene Engineering Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Zhongyuan Union Cell & Gene Engineering Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines